Both IRP1 and IRP2 are over-expressed in breast cancer, but only the overexpression of IRP2 is associated with decreased FTH1 and increased TFR1, resulting in an increase in the LIP, which may contribute to poor prognosis of some breast cancer patients [79]. Here, IREB2 is linked to breast cancer.